{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:04:17Z","timestamp":1780131857896,"version":"3.54.0"},"reference-count":88,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Bisphosphonates are used to increase bone strength in treating osteopenia and osteoporosis, but their use for increasing lumbar fusion rates has been controversial. The objective of this study was to determine if preoperative treatment with bisphosphonates affects the reoperation rates for nonunions (operative nonunion rates) following lumbar fusions in patients with osteopenia or osteoporosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors conducted a cohort study using data from the Kaiser Permanente Spine Registry. Patients (aged \u2265 50 years) with a diagnosis of osteopenia or osteoporosis who underwent primary elective lumbar fusions for degenerative disc disease, deformity, or spondylolisthesis were included in the cohort. Repeated spinal procedures at the index lumbar levels were noted through chart review. Reoperations for symptomatic nonunions (operative nonunions), time to nonunion, and the nonunion spine level(s) were also identified. The crude 2-year cumulative incidence of operative nonunions was calculated as 1 minus the Kaplan-Meier estimator. Cox proportional hazard regression was used to evaluate the association between preoperative bisphosphonate use and operative nonunion after adjustment for covariates. Analysis was stratified by osteopenia and osteoporosis diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The cohort comprised 1040 primary elective lumbar fusion patients, 408 with osteopenia and 632 with osteoporosis. Ninety-seven (23.8%) patients with osteopenia and 370 (58.5%) patients with osteoporosis were preoperative bisphosphonate users. For the osteopenia group, no operative nonunions were observed in patients with preoperative bisphosphonate, while the crude 2-year incidence was 2.44% (95% CI 0.63\u20134.22) in the nonuser group. For the osteoporotic group, after adjustment for covariates, no difference was observed in risk for operative nonunions between the preoperative bisphosphonate users and nonusers (HR 0.96, 95% CI 0.20\u20134.55, p = 0.964).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>To the authors\u2019 knowledge, this study presents one of the largest series of patients with the diagnosis of osteopenia or osteoporosis in whom the effects of preoperative bisphosphonates on lumbar fusions were evaluated using operative nonunion rates as an outcome measure. The results indicate that preoperative bisphosphonate use had no effect on the operative nonunion rates for patients with osteoporosis. Similar indications were not confirmed in osteopenia patients because of the low nonunion frequency. Further studies are warranted to the determine if preoperative and postoperative timing of bisphosphonate use has any effect on lumbar fusion rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2020.5.focus20262","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T09:30:46Z","timestamp":1596274246000},"page":"E12","source":"Crossref","is-referenced-by-count":18,"title":["Does the use of preoperative bisphosphonates in patients with osteopenia and osteoporosis affect lumbar fusion rates? Analysis from a national spine registry"],"prefix":"10.3171","volume":"49","author":[{"given":"Kern H.","family":"Guppy","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Permanente Medical Group, Sacramento;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla H.","family":"Chan","sequence":"additional","affiliation":[{"name":"Surgical Outcomes & Analysis, Kaiser Permanente, San Diego;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Prentice","sequence":"additional","affiliation":[{"name":"Surgical Outcomes & Analysis, Kaiser Permanente, San Diego;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth P.","family":"Norheim","sequence":"additional","affiliation":[{"name":"Department of Spinal Surgery, Southern California Permanente Medical Group, Downey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Harris","sequence":"additional","affiliation":[{"name":"Surgical Outcomes & Analysis, Kaiser Permanente, San Diego;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsimran S.","family":"Brara","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Southern California Permanente Medical Group, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"9","key":"b1","series-title":"Osteoporos Int","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00198-007-0370-8","article-title":"Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease","volume":"18","author":"Chin DK","year":"2007","unstructured":"Chin DK, Park JY, Yoon YS,  Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease. Osteoporos Int. 2007;18(9):1219\u20131224.10.1007\/s00198-007-0370-817387420"},{"issue":"2","key":"b2","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"163","DOI":"10.7812\/TPP\/12-008","article-title":"Risk factors for adjacent-segment failure following lumbar fixation with rigid instrumentation for degenerative instability","volume":"90","author":"Etebar S","year":"1999","unstructured":"Etebar S, Cahill DW. Risk factors for adjacent-segment failure following lumbar fixation with rigid instrumentation for degenerative instability. J Neurosurg. 1999;90(2)(suppl):163\u2013169.1019924410.7812\/TPP\/12-008"},{"issue":"21","key":"b3","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1097\/00007632-199411000-00008","article-title":"Effects of bone mineral density on pedicle screw fixation","volume":"19","author":"Halvorson TL","unstructured":"Halvorson TL, Kelley LA, Thomas KA,  Effects of bone mineral density on pedicle screw fixation. Spine (Phila Pa 1976). 1994;19(21):2415\u20132420.10.1097\/00007632-199411000-00008"},{"issue":"12","key":"b4","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.2106\/00004623-200612000-00019","article-title":"Surgical outcomes of posterior lumbar interbody fusion in elderly patients","volume":"88","author":"Okuda S","year":"2006","unstructured":"Okuda S, Oda T, Miyauchi A,  Surgical outcomes of posterior lumbar interbody fusion in elderly patients. J Bone Joint Surg Am. 2006;88(12):2714\u20132720.1714242210.2106\/00004623-200612000-00019"},{"issue":"10","key":"b5","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jama.2017.21995","article-title":"Treatment of osteoporosis","volume":"319","author":"Cotts KG","year":"2018","unstructured":"Cotts KG, Cifu AS. Treatment of osteoporosis. JAMA. 2018;319(10):1040\u20131041.10.1001\/jama.2017.2199529536084"},{"issue":"6","key":"b6","series-title":"Osteoporos Int","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell RG","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008;19(6):733\u2013759.10.1007\/s00198-007-0540-818214569"},{"issue":"1","key":"b7","series-title":"Clin Ther","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0149-2918(03)90005-1","article-title":"Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies","volume":"25","author":"Schimmer RC","year":"2003","unstructured":"Schimmer RC, Bauss F. Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies. Clin Ther. 2003;25(1):19\u201334.10.1016\/S0149-2918(03)90005-1"},{"issue":"5","key":"b8","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.spinee.2005.01.008","article-title":"The effects of the antiresorptive agents calcitonin and pamidronate on spine fusion in a rabbit model","volume":"5","author":"Babat LB","year":"2005","unstructured":"Babat LB, McLain R, Milks R,  The effects of the antiresorptive agents calcitonin and pamidronate on spine fusion in a rabbit model. Spine J. 2005;5(5):542\u2013547.10.1016\/j.spinee.2005.01.008"},{"issue":"4","key":"b9","series-title":"Eur Spine J","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00586-006-0212-y","article-title":"Effect of zoledronic acid in an L6-L7 rabbit spine fusion model","volume":"16","author":"Bransford R","year":"2007","unstructured":"Bransford R, Goergens E, Briody J,  Effect of zoledronic acid in an L6-L7 rabbit spine fusion model. Eur Spine J. 2007;16(4):557\u2013562.10.1007\/s00586-006-0212-y"},{"issue":"17","key":"b10","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"E1014","DOI":"10.1097\/BRS.0000000000002608","article-title":"Bisphosphonate and teriparatide use in thoracolumbar spinal fusion: a systematic review and meta-analysis of comparative studies","volume":"43","author":"Buerba RA","year":"2018","unstructured":"Buerba RA, Sharma A, Ziino C,  Bisphosphonate and teriparatide use in thoracolumbar spinal fusion: a systematic review and meta-analysis of comparative studies. Spine (Phila Pa 1976). 2018;43(17):E1014\u2013E1023.10.1097\/BRS.0000000000002608"},{"issue":"4","key":"b11","series-title":"Osteoporos Int","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s00198-015-3398-1","article-title":"Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion","volume":"27","author":"Chen F","year":"2016","unstructured":"Chen F, Dai Z, Kang Y,  Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion. Osteoporos Int. 2016;27(4):1469\u20131476.10.1007\/s00198-015-3398-1"},{"issue":"11","key":"b12","series-title":"Eur Spine J","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1007\/s00586-017-5286-1","article-title":"Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients","volume":"26","author":"Ding Q","year":"2017","unstructured":"Ding Q, Chen J, Fan J,  Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients. Eur Spine J. 2017;26(11):2969\u20132977.10.1007\/s00586-017-5286-128865035"},{"issue":"2","key":"b13","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.spinee.2012.03.035","article-title":"The effect of therapies for osteoporosis on spine fusion: a systematic review","volume":"13","author":"Hirsch BP","year":"2013","unstructured":"Hirsch BP, Unnanuntana A, Cunningham ME, Lane JM. The effect of therapies for osteoporosis on spine fusion: a systematic review. Spine J. 2013;13(2):190\u2013199.10.1016\/j.spinee.2012.03.03522658879"},{"issue":"22","key":"b14","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1097\/01.brs.0000186470.28070.7b","article-title":"Alendronate inhibits spine fusion in a rat model","volume":"30","author":"Huang RC","year":"2005","unstructured":"Huang RC, Khan SN, Sandhu HS,  Alendronate inhibits spine fusion in a rat model. Spine (Phila Pa 1976). 2005;30(22):2516\u20132522.10.1097\/01.brs.0000186470.28070.7b"},{"issue":"4","key":"b15","series-title":"Korean J Spine","doi-asserted-by":"publisher","first-page":"221","DOI":"10.14245\/kjs.2014.11.4.221","article-title":"Influence of alendronate and endplate degeneration to single level posterior lumbar spinal interbody fusion","volume":"11","author":"Kim SM","year":"2014","unstructured":"Kim SM, Rhee W, Ha S,  Influence of alendronate and endplate degeneration to single level posterior lumbar spinal interbody fusion. Korean J Spine. 2014;11(4):221\u2013226.2562098110.14245\/kjs.2014.11.4.221"},{"issue":"1","key":"b16","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1529-9430(03)00427-3","article-title":"The effect of alendronate sodium on spinal fusion: a rabbit model","volume":"4","author":"Lehman RA Jr","year":"2004","unstructured":"Lehman RA Jr, Kuklo TR, Freedman BA,  The effect of alendronate sodium on spinal fusion: a rabbit model. Spine J. 2004;4(1):36\u201343.10.1016\/S1529-9430(03)00427-314749192"},{"issue":"4","key":"b17","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00701-012-1283-7","article-title":"The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery","volume":"154","author":"Li C","year":"2012","unstructured":"Li C, Wang HR, Li XL,  The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery. Acta Neurochir (Wien). 2012;154(4):731\u2013738.10.1007\/s00701-012-1283-7"},{"key":"b18","series-title":"Drug Des Devel Ther","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.2147\/DDDT.S164548","article-title":"The effects of bisphosphonates on osteoporotic patients after lumbar fusion: a meta-analysis","volume":"12","author":"Liu WB","year":"2018","unstructured":"Liu WB, Zhao WT, Shen P, Zhang FJ. The effects of bisphosphonates on osteoporotic patients after lumbar fusion: a meta-analysis. Drug Des Devel Ther. 2018;12:2233\u20132240.10.2147\/DDDT.S16454830046237"},{"issue":"4","key":"b19","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3171\/2010.11.SPINE10245","article-title":"Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial","volume":"14","author":"Nagahama K","year":"2011","unstructured":"Nagahama K, Kanayama M, Togawa D,  Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial. J Neurosurg Spine. 2011;14(4):500\u2013507.2127554910.3171\/2010.11.SPINE10245"},{"issue":"18","key":"b20","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1097\/BRS.0b013e3181f49c47","article-title":"The influence of alendronate on spine fusion in an osteoporotic animal model","volume":"36","author":"Nakao S","year":"2011","unstructured":"Nakao S, Minamide A, Kawakami M,  The influence of alendronate on spine fusion in an osteoporotic animal model. Spine (Phila Pa 1976). 2011;36(18):1446\u20131452.10.1097\/BRS.0b013e3181f49c47"},{"issue":"8","key":"b21","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"E487","DOI":"10.1097\/BRS.0b013e31828826dd","article-title":"Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective","volume":"38","author":"Ohtori S","year":"2013","unstructured":"Ohtori S, Inoue G, Orita S,  Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine (Phila Pa 1976). 2013;38(8):E487\u2013E492.10.1097\/BRS.0b013e31828826dd"},{"issue":"4","key":"b22","series-title":"Clin Orthop Surg","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4055\/cios.2013.5.4.292","article-title":"The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion","volume":"5","author":"Park YS","year":"2013","unstructured":"Park YS, Kim HS, Baek SW,  The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion. Clin Orthop Surg. 2013;5(4):292\u2013297.10.4055\/cios.2013.5.4.29224340149"},{"issue":"6","key":"b23","series-title":"Bone","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.bone.2008.08.124","article-title":"The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis model","volume":"43","author":"Takahata M","year":"2008","unstructured":"Takahata M, Ito M, Abe Y,  The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis model. Bone. 2008;43(6):1057\u20131066.10.1016\/j.bone.2008.08.124"},{"issue":"1","key":"b24","series-title":"J Surg Res","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jss.2014.05.034","article-title":"Zoledronic acid infusion for lumbar interbody fusion in osteoporosis","volume":"192","author":"Tu CW","year":"2014","unstructured":"Tu CW, Huang KF, Hsu HT,  Zoledronic acid infusion for lumbar interbody fusion in osteoporosis. J Surg Res. 2014;192(1):112\u2013116.2494854510.1016\/j.jss.2014.05.034"},{"issue":"10","key":"b25","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1097\/01.brs.0000162929.19985.d2","article-title":"The influence of alendronate treatment and bone graft volume on posterior lateral spine fusion in a porcine model","volume":"30","author":"Xue Q","year":"2005","unstructured":"Xue Q, Li H, Zou X,  The influence of alendronate treatment and bone graft volume on posterior lateral spine fusion in a porcine model. Spine (Phila Pa 1976). 2005;30(10):1116\u20131121.10.1097\/01.brs.0000162929.19985.d2"},{"issue":"9","key":"b26","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/00007632-199307000-00010","article-title":"Can lumbar spine radiographs accurately determine fusion in postoperative patients? Correlation of routine radiographs with a second surgical look at lumbar fusions","volume":"18","author":"Blumenthal SL","year":"1993","unstructured":"Blumenthal SL, Gill K. Can lumbar spine radiographs accurately determine fusion in postoperative patients? Correlation of routine radiographs with a second surgical look at lumbar fusions. Spine (Phila Pa 1976). 1993;18(9):1186\u20131189.10.1097\/00007632-199307000-00010"},{"issue":"6","key":"b27","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.1097\/00007632-199106001-00017","article-title":"Correlation of radiologic assessment of lumbar spine fusions with surgical exploration","volume":"16","author":"Brodsky AE","year":"1991","unstructured":"Brodsky AE, Kovalsky ES, Khalil MA. Correlation of radiologic assessment of lumbar spine fusions with surgical exploration. Spine (Phila Pa 1976). 1991;16(6)(suppl):S261\u2013S265.10.1097\/00007632-199106001-00017"},{"issue":"7","key":"b28","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2106\/JBJS.G.01157","article-title":"Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial","volume":"91","author":"Dawson E","year":"2009","unstructured":"Dawson E, Bae HW, Burkus JK,  Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am. 2009;91(7):1604\u20131613.10.2106\/JBJS.G.01157"},{"issue":"5","key":"b29","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.spinee.2012.02.005","article-title":"Factors affecting reoperations after anterior cervical discectomy and fusion within and outside of a Federal Drug Administration investigational device exemption cervical disc replacement trial","volume":"12","author":"Singh K","year":"2012","unstructured":"Singh K, Phillips FM, Park DK,  Factors affecting reoperations after anterior cervical discectomy and fusion within and outside of a Federal Drug Administration investigational device exemption cervical disc replacement trial. Spine J. 2012;12(5):372\u2013378.10.1016\/j.spinee.2012.02.00522425784"},{"issue":"22","key":"b30","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1097\/BRS.0000000000000534","article-title":"Does bone morphogenetic protein change the operative nonunion rates in spine fusions?","volume":"39","author":"Guppy KH","year":"2014","unstructured":"Guppy KH, Paxton EW, Harris J,  Does bone morphogenetic protein change the operative nonunion rates in spine fusions? Spine (Phila Pa 1976). 2014;39(22):1831\u20131839.10.1097\/BRS.0000000000000534"},{"issue":"20","key":"b31","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1097\/BRS.0000000000001085","article-title":"Reoperation rates for symptomatic nonunions in anterior cervical fusions from a national spine registry","volume":"40","author":"Guppy KH","year":"2015","unstructured":"Guppy KH, Harris J, Paxton LW,  Reoperation rates for symptomatic nonunions in anterior cervical fusions from a national spine registry. Spine (Phila Pa 1976). 2015;40(20):1632\u20131637.10.1097\/BRS.0000000000001085"},{"issue":"4","key":"b32","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3171\/2015.7.SPINE15353","article-title":"Reoperation rates for symptomatic nonunions in posterior cervical (subaxial) fusions with and without bone morphogenetic protein in a cohort of 1158 patients","volume":"24","author":"Guppy KH","year":"2016","unstructured":"Guppy KH, Harris J, Chen J,  Reoperation rates for symptomatic nonunions in posterior cervical (subaxial) fusions with and without bone morphogenetic protein in a cohort of 1158 patients. J Neurosurg Spine. 2016;24(4):556\u2013564.10.3171\/2015.7.SPINE15353"},{"issue":"3","key":"b33","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3171\/2016.1.SPINE151330","article-title":"Reoperation rates for symptomatic nonunions in posterior cervicothoracic fusions with and without bone morphogenetic protein in a cohort of 450 patients","volume":"25","author":"Guppy KH","year":"2016","unstructured":"Guppy KH, Harris J, Chen J,  Reoperation rates for symptomatic nonunions in posterior cervicothoracic fusions with and without bone morphogenetic protein in a cohort of 450 patients. J Neurosurg Spine. 2016;25(3):309\u2013317.10.3171\/2016.1.SPINE151330"},{"issue":"19","key":"b34","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1001\/jama.287.19.2519","article-title":"Ethnic disparities in diabetic complications in an insured population","volume":"287","author":"Karter AJ","year":"2002","unstructured":"Karter AJ, Ferrara A, Liu JY,  Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287(19):2519\u20132527.10.1001\/jama.287.19.2519"},{"issue":"3","key":"b35","series-title":"Perm J","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data","volume":"16","author":"Koebnick C","year":"2012","unstructured":"Koebnick C, Langer-Gould AM, Gould MK,  Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J. 2012;16(3):37\u201341.10.7812\/TPP\/12-03123012597"},{"issue":"2","key":"b36","series-title":"Perm J","first-page":"36","article-title":"The Kaiser Permanente implant registries: effect on patient safety, quality improvement, cost effectiveness, and research opportunities","volume":"16","author":"Paxton EW","year":"2012","unstructured":"Paxton EW, Inacio MC, Kiley ML. The Kaiser Permanente implant registries: effect on patient safety, quality improvement, cost effectiveness, and research opportunities. Perm J. 2012;16(2):36\u201344."},{"issue":"4","key":"b37","series-title":"J Intern Med","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2796.2008.02010.x","article-title":"Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance","volume":"264","author":"Boonen S","year":"2008","unstructured":"Boonen S, Vanderschueren D, Venken K,  Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance. J Intern Med. 2008;264(4):315\u2013332.10.1111\/j.1365-2796.2008.02010.x18823505"},{"issue":"16","key":"b38","series-title":"Expert Opin Pharmacother","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1517\/14656566.8.16.2743","article-title":"Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis\u2014usefulness of alendronate and risedronate","volume":"8","author":"Iwamoto J","year":"2007","unstructured":"Iwamoto J, Takeda T, Sato Y. Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis\u2014usefulness of alendronate and risedronate. Expert Opin Pharmacother. 2007;8(16):2743\u20132756.10.1517\/14656566.8.16.274317956196"},{"issue":"10","key":"b39","series-title":"J Bone Miner Res","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/jbmr.119","article-title":"Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study","volume":"25","author":"Orwoll ES","year":"2010","unstructured":"Orwoll ES, Miller PD, Adachi JD,  Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study. J Bone Miner Res. 2010;25(10):2239\u20132250.2049935710.1002\/jbmr.119"},{"issue":"25","key":"b40","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","article-title":"fracture prevention with zoledronate in older women with osteopenia","volume":"379","author":"Reid IR","year":"2018","unstructured":"Reid IR, Horne AM, Mihov B,  fracture prevention with zoledronate in older women with osteopenia. N Engl J Med. 2018;379(25):2407\u20132416.10.1056\/NEJMoa180808230575489"},{"issue":"2","key":"b41","series-title":"Cureus","first-page":"e4146","article-title":"Role of bisphosphonate therapy in patients with osteopenia: a systemic review","volume":"11","author":"Iqbal SM","year":"2019","unstructured":"Iqbal SM, Qamar I, Zhi C,  Role of bisphosphonate therapy in patients with osteopenia: a systemic review. Cureus. 2019;11(2):e4146.31058029"},{"issue":"21","key":"b42","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1097\/00007632-199511000-00009","article-title":"Evaluation of lumbar spine fusion. Plain radiographs versus direct surgical exploration and observation","volume":"20","author":"Kant AP","year":"1995","unstructured":"Kant AP, Daum WJ, Dean SM, Uchida T. Evaluation of lumbar spine fusion. Plain radiographs versus direct surgical exploration and observation. Spine (Phila Pa 1976). 1995;20(21):2313\u20132317.10.1097\/00007632-199511000-00009"},{"issue":"9","key":"b43","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2106\/JBJS.16.00679","article-title":"Outcomes of posterolateral fusion with and without instrumentation and of interbody fusion for isthmic spondylolisthesis: a prospective study","volume":"99","author":"Endler P","year":"2017","unstructured":"Endler P, Ekman P, M\u00f6ller H, Gerdhem P. Outcomes of posterolateral fusion with and without instrumentation and of interbody fusion for isthmic spondylolisthesis: a prospective study. J Bone Joint Surg Am. 2017;99(9):743\u2013752.10.2106\/JBJS.16.0067928463918"},{"key":"b44","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"d7222","DOI":"10.1136\/bmj.d7222","article-title":"Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study","volume":"343","author":"Prieto-Alhambra D","year":"2011","unstructured":"Prieto-Alhambra D, Javaid MK, Judge A,  Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ. 2011;343:d7222.10.1136\/bmj.d7222"},{"issue":"9","key":"b1","series-title":"Osteoporos Int","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00198-007-0370-8","article-title":"Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease","volume":"18","author":"Chin DK","year":"2007","unstructured":"Chin DK, Park JY, Yoon YS,  Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease. Osteoporos Int. 2007;18(9):1219\u20131224.10.1007\/s00198-007-0370-817387420"},{"issue":"2","key":"b2","series-title":"J Neurosurg","first-page":"163","article-title":"Risk factors for adjacent-segment failure following lumbar fixation with rigid instrumentation for degenerative instability","volume":"90","author":"Etebar S","year":"1999","unstructured":"Etebar S, Cahill DW. Risk factors for adjacent-segment failure following lumbar fixation with rigid instrumentation for degenerative instability. J Neurosurg. 1999;90(2)(suppl):163\u2013169.10199244"},{"issue":"21","key":"b3","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1097\/00007632-199411000-00008","article-title":"Effects of bone mineral density on pedicle screw fixation","volume":"19","author":"Halvorson TL","unstructured":"Halvorson TL, Kelley LA, Thomas KA,  Effects of bone mineral density on pedicle screw fixation. Spine (Phila Pa 1976). 1994;19(21):2415\u20132420.10.1097\/00007632-199411000-00008"},{"issue":"12","key":"b4","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.2106\/00004623-200612000-00019","article-title":"Surgical outcomes of posterior lumbar interbody fusion in elderly patients","volume":"88","author":"Okuda S","year":"2006","unstructured":"Okuda S, Oda T, Miyauchi A,  Surgical outcomes of posterior lumbar interbody fusion in elderly patients. J Bone Joint Surg Am. 2006;88(12):2714\u20132720.1714242210.2106\/00004623-200612000-00019"},{"issue":"10","key":"b5","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jama.2017.21995","article-title":"Treatment of osteoporosis","volume":"319","author":"Cotts KG","year":"2018","unstructured":"Cotts KG, Cifu AS. Treatment of osteoporosis. JAMA. 2018;319(10):1040\u20131041.10.1001\/jama.2017.2199529536084"},{"issue":"6","key":"b6","series-title":"Osteoporos Int","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell RG","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008;19(6):733\u2013759.10.1007\/s00198-007-0540-818214569"},{"issue":"1","key":"b7","series-title":"Clin Ther","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0149-2918(03)90005-1","article-title":"Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies","volume":"25","author":"Schimmer RC","year":"2003","unstructured":"Schimmer RC, Bauss F. Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies. Clin Ther. 2003;25(1):19\u201334.10.1016\/S0149-2918(03)90005-1"},{"issue":"5","key":"b8","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.spinee.2005.01.008","article-title":"The effects of the antiresorptive agents calcitonin and pamidronate on spine fusion in a rabbit model","volume":"5","author":"Babat LB","year":"2005","unstructured":"Babat LB, McLain R, Milks R,  The effects of the antiresorptive agents calcitonin and pamidronate on spine fusion in a rabbit model. Spine J. 2005;5(5):542\u2013547.10.1016\/j.spinee.2005.01.008"},{"issue":"4","key":"b9","series-title":"Eur Spine J","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00586-006-0212-y","article-title":"Effect of zoledronic acid in an L6-L7 rabbit spine fusion model","volume":"16","author":"Bransford R","year":"2007","unstructured":"Bransford R, Goergens E, Briody J,  Effect of zoledronic acid in an L6-L7 rabbit spine fusion model. Eur Spine J. 2007;16(4):557\u2013562.10.1007\/s00586-006-0212-y"},{"issue":"17","key":"b10","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"E1014","DOI":"10.1097\/BRS.0000000000002608","article-title":"Bisphosphonate and teriparatide use in thoracolumbar spinal fusion: a systematic review and meta-analysis of comparative studies","volume":"43","author":"Buerba RA","year":"2018","unstructured":"Buerba RA, Sharma A, Ziino C,  Bisphosphonate and teriparatide use in thoracolumbar spinal fusion: a systematic review and meta-analysis of comparative studies. Spine (Phila Pa 1976). 2018;43(17):E1014\u2013E1023.10.1097\/BRS.0000000000002608"},{"issue":"4","key":"b11","series-title":"Osteoporos Int","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s00198-015-3398-1","article-title":"Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion","volume":"27","author":"Chen F","year":"2016","unstructured":"Chen F, Dai Z, Kang Y,  Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion. Osteoporos Int. 2016;27(4):1469\u20131476.10.1007\/s00198-015-3398-1"},{"issue":"11","key":"b12","series-title":"Eur Spine J","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1007\/s00586-017-5286-1","article-title":"Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients","volume":"26","author":"Ding Q","year":"2017","unstructured":"Ding Q, Chen J, Fan J,  Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients. Eur Spine J. 2017;26(11):2969\u20132977.10.1007\/s00586-017-5286-128865035"},{"issue":"2","key":"b13","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.spinee.2012.03.035","article-title":"The effect of therapies for osteoporosis on spine fusion: a systematic review","volume":"13","author":"Hirsch BP","year":"2013","unstructured":"Hirsch BP, Unnanuntana A, Cunningham ME, Lane JM. The effect of therapies for osteoporosis on spine fusion: a systematic review. Spine J. 2013;13(2):190\u2013199.10.1016\/j.spinee.2012.03.03522658879"},{"issue":"22","key":"b14","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1097\/01.brs.0000186470.28070.7b","article-title":"Alendronate inhibits spine fusion in a rat model","volume":"30","author":"Huang RC","year":"2005","unstructured":"Huang RC, Khan SN, Sandhu HS,  Alendronate inhibits spine fusion in a rat model. Spine (Phila Pa 1976). 2005;30(22):2516\u20132522.10.1097\/01.brs.0000186470.28070.7b"},{"issue":"4","key":"b15","series-title":"Korean J Spine","doi-asserted-by":"publisher","first-page":"221","DOI":"10.14245\/kjs.2014.11.4.221","article-title":"Influence of alendronate and endplate degeneration to single level posterior lumbar spinal interbody fusion","volume":"11","author":"Kim SM","year":"2014","unstructured":"Kim SM, Rhee W, Ha S,  Influence of alendronate and endplate degeneration to single level posterior lumbar spinal interbody fusion. Korean J Spine. 2014;11(4):221\u2013226.2562098110.14245\/kjs.2014.11.4.221"},{"issue":"1","key":"b16","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1529-9430(03)00427-3","article-title":"The effect of alendronate sodium on spinal fusion: a rabbit model","volume":"4","author":"Lehman RA Jr","year":"2004","unstructured":"Lehman RA Jr, Kuklo TR, Freedman BA,  The effect of alendronate sodium on spinal fusion: a rabbit model. Spine J. 2004;4(1):36\u201343.10.1016\/S1529-9430(03)00427-314749192"},{"issue":"4","key":"b17","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00701-012-1283-7","article-title":"The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery","volume":"154","author":"Li C","year":"2012","unstructured":"Li C, Wang HR, Li XL,  The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery. Acta Neurochir (Wien). 2012;154(4):731\u2013738.10.1007\/s00701-012-1283-7"},{"key":"b18","series-title":"Drug Des Devel Ther","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.2147\/DDDT.S164548","article-title":"The effects of bisphosphonates on osteoporotic patients after lumbar fusion: a meta-analysis","volume":"12","author":"Liu WB","year":"2018","unstructured":"Liu WB, Zhao WT, Shen P, Zhang FJ. The effects of bisphosphonates on osteoporotic patients after lumbar fusion: a meta-analysis. Drug Des Devel Ther. 2018;12:2233\u20132240.10.2147\/DDDT.S16454830046237"},{"issue":"4","key":"b19","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3171\/2010.11.SPINE10245","article-title":"Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial","volume":"14","author":"Nagahama K","year":"2011","unstructured":"Nagahama K, Kanayama M, Togawa D,  Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial. J Neurosurg Spine. 2011;14(4):500\u2013507.2127554910.3171\/2010.11.SPINE10245"},{"issue":"18","key":"b20","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1097\/BRS.0b013e3181f49c47","article-title":"The influence of alendronate on spine fusion in an osteoporotic animal model","volume":"36","author":"Nakao S","year":"2011","unstructured":"Nakao S, Minamide A, Kawakami M,  The influence of alendronate on spine fusion in an osteoporotic animal model. Spine (Phila Pa 1976). 2011;36(18):1446\u20131452.10.1097\/BRS.0b013e3181f49c47"},{"issue":"8","key":"b21","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"E487","DOI":"10.1097\/BRS.0b013e31828826dd","article-title":"Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective","volume":"38","author":"Ohtori S","year":"2013","unstructured":"Ohtori S, Inoue G, Orita S,  Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine (Phila Pa 1976). 2013;38(8):E487\u2013E492.10.1097\/BRS.0b013e31828826dd"},{"issue":"4","key":"b22","series-title":"Clin Orthop Surg","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4055\/cios.2013.5.4.292","article-title":"The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion","volume":"5","author":"Park YS","year":"2013","unstructured":"Park YS, Kim HS, Baek SW,  The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion. Clin Orthop Surg. 2013;5(4):292\u2013297.10.4055\/cios.2013.5.4.29224340149"},{"issue":"6","key":"b23","series-title":"Bone","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.bone.2008.08.124","article-title":"The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis model","volume":"43","author":"Takahata M","year":"2008","unstructured":"Takahata M, Ito M, Abe Y,  The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis model. Bone. 2008;43(6):1057\u20131066.10.1016\/j.bone.2008.08.124"},{"issue":"1","key":"b24","series-title":"J Surg Res","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jss.2014.05.034","article-title":"Zoledronic acid infusion for lumbar interbody fusion in osteoporosis","volume":"192","author":"Tu CW","year":"2014","unstructured":"Tu CW, Huang KF, Hsu HT,  Zoledronic acid infusion for lumbar interbody fusion in osteoporosis. J Surg Res. 2014;192(1):112\u2013116.2494854510.1016\/j.jss.2014.05.034"},{"issue":"10","key":"b25","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1097\/01.brs.0000162929.19985.d2","article-title":"The influence of alendronate treatment and bone graft volume on posterior lateral spine fusion in a porcine model","volume":"30","author":"Xue Q","year":"2005","unstructured":"Xue Q, Li H, Zou X,  The influence of alendronate treatment and bone graft volume on posterior lateral spine fusion in a porcine model. Spine (Phila Pa 1976). 2005;30(10):1116\u20131121.10.1097\/01.brs.0000162929.19985.d2"},{"issue":"9","key":"b26","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/00007632-199307000-00010","article-title":"Can lumbar spine radiographs accurately determine fusion in postoperative patients? Correlation of routine radiographs with a second surgical look at lumbar fusions","volume":"18","author":"Blumenthal SL","year":"1993","unstructured":"Blumenthal SL, Gill K. Can lumbar spine radiographs accurately determine fusion in postoperative patients? Correlation of routine radiographs with a second surgical look at lumbar fusions. Spine (Phila Pa 1976). 1993;18(9):1186\u20131189.10.1097\/00007632-199307000-00010"},{"issue":"6","key":"b27","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.1097\/00007632-199106001-00017","article-title":"Correlation of radiologic assessment of lumbar spine fusions with surgical exploration","volume":"16","author":"Brodsky AE","year":"1991","unstructured":"Brodsky AE, Kovalsky ES, Khalil MA. Correlation of radiologic assessment of lumbar spine fusions with surgical exploration. Spine (Phila Pa 1976). 1991;16(6)(suppl):S261\u2013S265.10.1097\/00007632-199106001-00017"},{"issue":"7","key":"b28","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2106\/JBJS.G.01157","article-title":"Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial","volume":"91","author":"Dawson E","year":"2009","unstructured":"Dawson E, Bae HW, Burkus JK,  Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am. 2009;91(7):1604\u20131613.10.2106\/JBJS.G.01157"},{"issue":"5","key":"b29","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.spinee.2012.02.005","article-title":"Factors affecting reoperations after anterior cervical discectomy and fusion within and outside of a Federal Drug Administration investigational device exemption cervical disc replacement trial","volume":"12","author":"Singh K","year":"2012","unstructured":"Singh K, Phillips FM, Park DK,  Factors affecting reoperations after anterior cervical discectomy and fusion within and outside of a Federal Drug Administration investigational device exemption cervical disc replacement trial. Spine J. 2012;12(5):372\u2013378.10.1016\/j.spinee.2012.02.00522425784"},{"issue":"22","key":"b30","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1097\/BRS.0000000000000534","article-title":"Does bone morphogenetic protein change the operative nonunion rates in spine fusions?","volume":"39","author":"Guppy KH","year":"2014","unstructured":"Guppy KH, Paxton EW, Harris J,  Does bone morphogenetic protein change the operative nonunion rates in spine fusions? Spine (Phila Pa 1976). 2014;39(22):1831\u20131839.10.1097\/BRS.0000000000000534"},{"issue":"20","key":"b31","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1097\/BRS.0000000000001085","article-title":"Reoperation rates for symptomatic nonunions in anterior cervical fusions from a national spine registry","volume":"40","author":"Guppy KH","year":"2015","unstructured":"Guppy KH, Harris J, Paxton LW,  Reoperation rates for symptomatic nonunions in anterior cervical fusions from a national spine registry. Spine (Phila Pa 1976). 2015;40(20):1632\u20131637.10.1097\/BRS.0000000000001085"},{"issue":"4","key":"b32","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3171\/2015.7.SPINE15353","article-title":"Reoperation rates for symptomatic nonunions in posterior cervical (subaxial) fusions with and without bone morphogenetic protein in a cohort of 1158 patients","volume":"24","author":"Guppy KH","year":"2016","unstructured":"Guppy KH, Harris J, Chen J,  Reoperation rates for symptomatic nonunions in posterior cervical (subaxial) fusions with and without bone morphogenetic protein in a cohort of 1158 patients. J Neurosurg Spine. 2016;24(4):556\u2013564.10.3171\/2015.7.SPINE15353"},{"issue":"3","key":"b33","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3171\/2016.1.SPINE151330","article-title":"Reoperation rates for symptomatic nonunions in posterior cervicothoracic fusions with and without bone morphogenetic protein in a cohort of 450 patients","volume":"25","author":"Guppy KH","year":"2016","unstructured":"Guppy KH, Harris J, Chen J,  Reoperation rates for symptomatic nonunions in posterior cervicothoracic fusions with and without bone morphogenetic protein in a cohort of 450 patients. J Neurosurg Spine. 2016;25(3):309\u2013317.10.3171\/2016.1.SPINE151330"},{"issue":"19","key":"b34","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1001\/jama.287.19.2519","article-title":"Ethnic disparities in diabetic complications in an insured population","volume":"287","author":"Karter AJ","year":"2002","unstructured":"Karter AJ, Ferrara A, Liu JY,  Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287(19):2519\u20132527.10.1001\/jama.287.19.2519"},{"issue":"3","key":"b35","series-title":"Perm J","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data","volume":"16","author":"Koebnick C","year":"2012","unstructured":"Koebnick C, Langer-Gould AM, Gould MK,  Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J. 2012;16(3):37\u201341.10.7812\/TPP\/12-03123012597"},{"issue":"2","key":"b36","series-title":"Perm J","first-page":"36","article-title":"The Kaiser Permanente implant registries: effect on patient safety, quality improvement, cost effectiveness, and research opportunities","volume":"16","author":"Paxton EW","year":"2012","unstructured":"Paxton EW, Inacio MC, Kiley ML. The Kaiser Permanente implant registries: effect on patient safety, quality improvement, cost effectiveness, and research opportunities. Perm J. 2012;16(2):36\u201344."},{"issue":"4","key":"b37","series-title":"J Intern Med","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2796.2008.02010.x","article-title":"Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance","volume":"264","author":"Boonen S","year":"2008","unstructured":"Boonen S, Vanderschueren D, Venken K,  Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance. J Intern Med. 2008;264(4):315\u2013332.10.1111\/j.1365-2796.2008.02010.x18823505"},{"issue":"16","key":"b38","series-title":"Expert Opin Pharmacother","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1517\/14656566.8.16.2743","article-title":"Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis\u2014usefulness of alendronate and risedronate","volume":"8","author":"Iwamoto J","year":"2007","unstructured":"Iwamoto J, Takeda T, Sato Y. Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis\u2014usefulness of alendronate and risedronate. Expert Opin Pharmacother. 2007;8(16):2743\u20132756.10.1517\/14656566.8.16.274317956196"},{"issue":"10","key":"b39","series-title":"J Bone Miner Res","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/jbmr.119","article-title":"Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study","volume":"25","author":"Orwoll ES","year":"2010","unstructured":"Orwoll ES, Miller PD, Adachi JD,  Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study. J Bone Miner Res. 2010;25(10):2239\u20132250.2049935710.1002\/jbmr.119"},{"issue":"25","key":"b40","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","article-title":"fracture prevention with zoledronate in older women with osteopenia","volume":"379","author":"Reid IR","year":"2018","unstructured":"Reid IR, Horne AM, Mihov B,  fracture prevention with zoledronate in older women with osteopenia. N Engl J Med. 2018;379(25):2407\u20132416.10.1056\/NEJMoa180808230575489"},{"issue":"2","key":"b41","series-title":"Cureus","first-page":"e4146","article-title":"Role of bisphosphonate therapy in patients with osteopenia: a systemic review","volume":"11","author":"Iqbal SM","year":"2019","unstructured":"Iqbal SM, Qamar I, Zhi C,  Role of bisphosphonate therapy in patients with osteopenia: a systemic review. Cureus. 2019;11(2):e4146.31058029"},{"issue":"21","key":"b42","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1097\/00007632-199511000-00009","article-title":"Evaluation of lumbar spine fusion. Plain radiographs versus direct surgical exploration and observation","volume":"20","author":"Kant AP","year":"1995","unstructured":"Kant AP, Daum WJ, Dean SM, Uchida T. Evaluation of lumbar spine fusion. Plain radiographs versus direct surgical exploration and observation. Spine (Phila Pa 1976). 1995;20(21):2313\u20132317.10.1097\/00007632-199511000-00009"},{"issue":"9","key":"b43","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2106\/JBJS.16.00679","article-title":"Outcomes of posterolateral fusion with and without instrumentation and of interbody fusion for isthmic spondylolisthesis: a prospective study","volume":"99","author":"Endler P","year":"2017","unstructured":"Endler P, Ekman P, M\u00f6ller H, Gerdhem P. Outcomes of posterolateral fusion with and without instrumentation and of interbody fusion for isthmic spondylolisthesis: a prospective study. J Bone Joint Surg Am. 2017;99(9):743\u2013752.10.2106\/JBJS.16.0067928463918"},{"key":"b44","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"d7222","DOI":"10.1136\/bmj.d7222","article-title":"Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study","volume":"343","author":"Prieto-Alhambra D","year":"2011","unstructured":"Prieto-Alhambra D, Javaid MK, Judge A,  Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ. 2011;343:d7222.10.1136\/bmj.d7222"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/49\/2\/article-pE12.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/49\/2\/article-pE12.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/49\/2\/article-pE12.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:35:19Z","timestamp":1780130119000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/49\/2\/article-pE12.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":88,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2020.5.focus20262","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}